GlassScriptPhysician profile
Luis J Morales
NPI 1265456537
$1,564.70
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $81.53 · 2021: $35.34 · 2022: $661 · 2023: $336 · 2024: $53.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.97 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $443.07 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $198.26 | 2022-2023 | Ova1 |
| Abbvie INC. | $126.07 | 2019-2022 | |
| Novo Nordisk INC | $117.71 | 2019 | |
| Astellas Pharma US INC | $107.49 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $81.89 | 2021-2024 | |
| Channel Medsystems, INC. | $58.25 | 2022 | |
| Baxter Healthcare | $53.86 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $45.89 | 2019 | |
| Hologic Sales and Service, LLC | $45.80 | 2020-2023 | Aptima, Thinprep 2000 Processor |
| Roche Diagnostics Corporation | $39.19 | 2019 | |
| Organon LLC | $35.18 | 2023 | Jada System |
| Ethicon US, LLC | $34.47 | 2019 | |
| Exeltis, USA INC. | $29.46 | 2020-2023 | Slynd |
| Amag Pharmaceuticals, INC. | $26.33 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.00 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.06 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Coopersurgical, INC. | $15.02 | 2019 | |
| Merck Sharp & Dohme LLC | $13.41 | 2019 | |
| Avion Pharmaceuticals | $13.38 | 2022 | |
| Lupin INC. | $12.77 | 2019 | |
| Pfizer INC. | $12.39 | 2019 | |
| Therapeuticsmd, INC. | $12.35 | 2019 | |
| Ascend Therapeutics US, LLC | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.